OBJECTIVE
To investigate the clinical, genetic, and neuroradiologic data of biotin-responsive basal ganglia disease (BBGD) and clarify the disease spectrum.
METHODS
We first investigated all patients attending our Division of Pediatric Neurology with a genetically proven diagnosis of BBGD between